Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling PathwayDonglai Chen, Yongbing Chen, Jinhui Wang et al.|Frontiers in Pharmacology|2018Cited by 48
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinomaXuejun Xu, Donglai Chen|Cancer Medicine|2023Cited by 14